Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biocon Biologics Receives Further Investment As Value Hits $3.5bn
Tata Capital Takes 0.85% Holding
Jul 31 2020
•
By
Dean Rudge
Biocon has offloaded another sliver of equity in Biocon Biologics • Source: Shutterstock
More from Deals
More from Business